KYRIAKOS ORFANAKOS

Dr. KYRIAKOS ORFANAKOS

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
KOKYRIAKOS ORFANAKOS
KYRIAKOS ORFANAKOS
Konstantinos AlifierisKonstantinos Alifieris
Konstantinos Alifieris
EVEmmanouil Verigos
Emmanouil Verigos
MDMaria Deligiorgi
Maria Deligiorgi
KVKOSMAS Verigos
KOSMAS Verigos
DTDimitrios Trafalis
Dimitrios Trafalis
Ionizing radiation is strongly linked to direct or indirect DNA damage, as with the production of reactive oxygen species (ROS), which in turn produce DNA damage products, such as 8-hydroxy-2-deoxyguanosine (8-OHdG). In this study, we aimed to investigate the formation of 8-OHdG after irradiation in patients with non-small cell cancer (NSCLC) and its use as a biomarker. Sixteen patients with squamous and thirty-six patients with non-squamous pathology were included. An enzyme-linked-immunosorbent assay (ELISA) was performed before and after radiation. A dose-dependent relationship was confirmed: 8-OHdG plasma concentrations, increased in the total of NSCLC patients and specifically with a linear correlation in non-squamous pathology; in squamous histology, after an initial increase, a significant decrease followed after 20 Gy dose of irradiation. The pretreatment total irradiated tumor volume (cm3) was positively correlated with 8-OHdG levels in patients with squamous histology. When plotting the 8-OHdG plasma concentration at a 10 Gy irradiation dose to the baseline, the AUC was 0.873 (95% CI 0.614–0.984), p < 0.0001, with an associated criterion value of >1378 as a cutoff (sensitivity 72.7%, specificity 100%). When normalizing this ratio to BSA, the associated criterion cutoff value was >708 (sensitivity of 100%, specificity 80%). Lastly, 8-OHdG levels were closely related with the development of radiation-induced toxicities.

1 October 2020 in Dose-Response
Verified
Journal Article
Open access
PDF file
KVKosmas E. Verigos
Kosmas E. Verigos
SSSofia Sagredou
Sofia Sagredou
KOKYRIAKOS ORFANAKOS
KYRIAKOS ORFANAKOS
PDPanayiotis Dalezis
Panayiotis Dalezis
DTDimitrios Trafalis
Dimitrios Trafalis
It is widely known that ionizing irradiation is strongly linked to the production of reactive oxygen (ROS) and nitrative species (RNS) through which DNA damage products like 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-nitroguanine (8-NG) are generated, respectively. In the present study, we aimed to investigate the formation of 8-OHdG and 8-NG upon irradiation and to further explore whether alterations in their concentration levels are related to the administered radiation doses and exposure time. Our research work was conducted in blood serum samples collected from 33 breast cancer patients who received adjuvant radiotherapy. The detection of 8-OHdG and 8-NG was assessed by enzyme-linked immunosorbent assay. Our results suggest that both, 8-OHdG and 8-NG, were formed during the radiation regimen. Significant correlations with radiation dose were also demonstrated by the dose-response curves of 8-OHdG and 8-NG, fitted by logarithmic distribution and polynomial regression, respectively. More precisely, 8-OHdG and 8-NG concentrations (ng/mL) were considerably increased when patients received ionizing radiation up to 30 Gy whereas irradiation over 30 Gy did not induce any further increases. The current study supports a) the production of 8-OHdG and 8-NG during radiotherapy and b) significant correlations between either 8-OHdG or 8-NG levels and radiation doses, indicating a radiation-dose-dependent relationship.

11 January 2017 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
Konstantinos AlifierisKonstantinos Alifieris
Konstantinos Alifieris
KOKYRIAKOS ORFANAKOS
KYRIAKOS ORFANAKOS
APAristina Papanota
Aristina Papanota
GSGeorge P. Stathopoulos
George P. Stathopoulos
NSNikolaos Sitaras
Nikolaos Sitaras
DTDimitrios T. Trafalis
Dimitrios T. Trafalis

Verified
Journal Article
Open access
PDF file
PKPetros Nikolaos Karamanakos
Petros Nikolaos Karamanakos
MFMaria Fouka
Maria Fouka
DADiamanto Aretha
Diamanto Aretha
EPEleftheria Panteli
Eleftheria Panteli
IPIOANNIS PANOPOULOS
IOANNIS PANOPOULOS
APOSTOLOS E. PAPALOISAPOSTOLOS E. PAPALOIS
APOSTOLOS E. PAPALOIS
Glioblastoma (GBM) is the most common and most aggressive malignant primary brain tumor in adults with a median survival of 15 months. One of the main factors responsible for the poor prognosis of GBM is resistance to treatment with temozolomide (TMZ), which has been attributed—among other factors—to autophagy. Preclinical studies have shown that the combination of disulfiram (DSF) with copper (Cu) possesses anti-GBM activity, through various mechanisms, including re-sensitization to TMZ. Herein, we tested for the first time the effects of DSF and Cu in combination with TMZ on the survival of Fischer rats bearing F98 glioma, a model characterized by inherent resistance to TMZ. Tumor size evaluation by Magnetic Resonance Imaging as well as immunofluorescence analysis of two autophagy markers, namely microtubule-associated protein 1 light chain 3 (LC3) and sequestosome-1 (SQSTM1)/p62 (p62), were also performed. According to our results, TMZ-DSF-Cu significantly increased mean survival and induced both LC3 and p62 autophagy markers. Interestingly, these results could not be achieved in the absence of Cu, neither in the presence of TMZ alone, suggesting the importance of combining DSF with Cu in order to sensitize glioma to TMZ, presumably via implication of autophagy modulation.

22 September 2025 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
EVEmmanouil K. Verigos
Emmanouil K. Verigos
SSSofia Sagredou
Sofia Sagredou
KVKOSMAS Verigos
KOSMAS Verigos
KOKYRIAKOS ORFANAKOS
KYRIAKOS ORFANAKOS
Konstantinos AlifierisKonstantinos Alifieris
Konstantinos Alifieris
DTDimitrios Trafalis
Dimitrios Trafalis
Aim: During radiation treatment, reactive oxygen species (ROS) and nitrogen species (RNS) are produced and, by extension, DNA adducts known as 8-hydroxy-2′-deoxyguanosine (8-OHdG) and 8-nitroguanine (8-NG), respectively. However, one of the most common side effects induced by radiotherapy is skin toxicity, which affects patients’ quality of life. In the present study, we aimed to investigate the potential predictive value of 8-OHdG and 8-NG by exploring the correlations between the alterations in the concentration levels of the two lesions and radiation-induced tissue injury upon exposure to external beam radiotherapy. Methods: For the purpose of this work, we collected blood serum samples from 33 breast cancer patients who received adjuvant radiotherapy. To conduct statistical analysis, we used: (1) linear adjustment to correlate the percent changes of 8-OHdG and 8-NG with the degree of toxicity; and (2) polynomial adaptation and exponential fitting to correlate the percent changes of 8-OHdG and 8-NG with the correlation coefficient r for the development of radiation dermatitis, respectively. Results: According to our findings, there is a statistically significant correlation between the alterations in the 8-OHdG and 8-NG levels and skin grade toxicity across time and varying radiation doses (p < 0.05). Conclusions: Both DNA lesions seem to possess a promising predictive role in radiation dermatitis, while the severity and exact grade of radiation-induced skin toxicity can be determined.

17 February 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Konstantinos AlifierisKonstantinos Alifieris
Konstantinos Alifieris
PDPanagiotis Dalezis
Panagiotis Dalezis
SSSofia Sagredou
Sofia Sagredou
IAIoanna A. Anastasiou
Ioanna A. Anastasiou
MDMaria Deligiorgi
Maria Deligiorgi
DTDimitrios Trafalis
Dimitrios Trafalis
Background: Colorectal and pancreatic cancers remain therapeutically challenging, with limitations in efficacy and limitations due to toxicity from conventional antimetabolites such as 5-fluorouracil (5-FU), methotrexate (MTX), and gemcitabine (GEM). Steroidal conjugation offers an approach to enhance selectivity and toxicokinetics. Methods: Five novel hybrid homo-aza (lactam) steroidal antimetabolites (GE23, CS18, CS23, KA44, MV16) were synthesized and tested against three pancreatic and four colorectal carcinoma cell lines with distinct molecular characteristics. Antiproliferative activity (MTT), apoptosis (Annexin V/PI), and cell cycle effects were assessed. Thymidylate synthase (TS) and dihydrofolate reductase (DHFR) inhibition was examined via molecular docking, Western blot, and enzymatic assays. Correlations between docking binding scores (DBS) and biological data were analyzed, and effects were compared with reference drugs (5-FU, MTX, GEM). Results: CS23, CS18, and KA44 exhibited the most potent cytostatic activity (mean GI50 10–80 µM). CS23 also induced high cytocidal effects, strong apoptosis (40% at 72 h), and G1/S arrest. Moreover, docking predicted the high binding affinity of CS23 for both TS (−11.2 kcal/mol) and DHFR (−11.5 kcal/mol), which was validated by Western blot and enzymatic inhibition (IC50 ≈ 20 nM). Correlation analyses showed significant relationships between hybrid steroidal antimetabolites’ cytostatic efficacy and DBS for TS (r = −0.75) and DHFR (r = −0.76), and combined DBS values predicted growth inhibition (r = −0.81, p < 0.01). No simple, universal correlation with single mutations of KRAS, BRAF, PI3K, or TP53 was found. Conclusions: Lactam steroidal antimetabolite hybrids, particularly CS23, act as dual TS/DHFR inhibitors, inducing apoptosis and cell cycle arrest with improved selectivity. Their strong in silico–in vitro concordance provides a compelling preclinical rationale for further evaluation of steroidal antimetabolites as next-generation therapeutics for resistant gastrointestinal malignancies.